Cancer treatment is a challenging and highly stressful time for patients – but it also brings dangers for their cardiovascular health. Since cancer patients have on average a 2-6 times higher cardiovascular disease mortality risk than the general population1, prompt, reliable identification of at-risk patients is crucial. And once treatment is underway, close monitoring could help cardiologists detect potential biomarkers that may indicate the early stages of cardiac toxicity.
The recently published European Society of Cardiology (ESC) Guidelines for Cardio-oncology (available here2) reflect these priorities for the prevention and monitoring of cardiotoxicity risks. And with our comprehensive workflow solutions and advanced cardiovascular ultrasound systems, we’re ready to support you and your patients every step of the way along their cancer treatment journey.
Worldwide, an estimated
28.4 million new cancer cases are projected to occur in 2040,
a 47% rise from 2020 – making cardiology care for cancer survivors increasingly important3
Sometimes, our patients must move quickly between the cardio-oncology unit, echo lab and outpatient clinic – so we need to be very fast. We need to access reports very quickly – maybe even within an hour – so that’s why the cardio-oncology workflow needs to be perfect.”
Dr Jorge Solis, Hospital Universitario 12 Octubre, Madrid, Spain
To improve the integration of echocardiography in cardio-oncology, we need advanced echo tools that will work for large numbers of patients and be able to translate data into clear conclusions to help in clinical decision-making."
Dr Teresa López-Fernández, MD
La Paz University Hospital, IdiPAZ, CIBER CV, Madrid, Spain
Collaboration today is crucial because once you have made your diagnosis, you need to plan the treatment of the patient. Above all, you need to speak the same lan- guage – which is why it is so important to have a system in which you have all the data of your patients – from EKG, to echo, to cardiac CT.”
Dr Valentina Volpato, Nuovo Galeazzi Hospital, Milan, Italy
Access to patient data in a single place, ranging from ECG, blood pressure and biomarker data to high-quality images, is essential in empowering cardio-oncology care teams. Having this information in a longitudinal, patient-centric view that can be used from anywhere, by anyone, allows the team to speak the same language – regardless of tools, location or dialect.
You are about to visit a Philips global content page
Continue
We aim to empower cardiologists to defne robust baseline risk predictors for cardiotoxicity, through the ability to perform comparable, reproducible risk stratifcation assessments. We can do this by delivering solutions and capabilities that facilitate a highly standardized, easy-to-follow approach to cardio-oncology care and cardiotoxicity risk management.
You are about to visit a Philips global content page
Continue
The initial baseline assessment includes a comprehensive transthoracic echo exam (TTE) including a precise assessment of cardiac function (left, right and atrial function). Our AI-driven tools allow you to perform a full exam with high-quality 2D and 3D imaging, giving you a strong foundation for risk stratifcation, and alleviates the need for additional user training.
By using these technologies, users can capture superb images and solid, robust quantifcation for accurate, reproducible and consistent measurements that inform and guide the onward patient journey. Moreover, if this process does not provide the necessary level of clarity, the clinician is able to compare results with other modalities, such as MR, to better connect the dots and defne the best way forward.
You are about to visit a Philips global content page
Continue
No matter which clinician performs a scan, which platform is used or who reads the scan results, the scan protocol should be standardized and reproducible. With our solutions and capabilities, the scan process takes less than three minutes per exam – including strain and ejection fraction – and provides a vital foundation for determining how often the patient will need to be treated.
You are about to visit a Philips global content page
ContinueSolutions
EPIQ CVx, our premium cardiovascular ultrasound system built on our innovative, modular, industry-leading ultrasound platform, has powerful AI-based capabilities and advanced diagnostic solutions to help you transcend today's complexities and propel echocardiography into the next dimension. This enables you to achieve greater consistency, accessible innovation, smarter workflows, and easier scalability.
Affiniti CVx, built on the Philips innovative cardiovascular ultrasound platform, has powerful AI-based capabilities to help you transcend today's complexities and propel echocardiography into the next dimension. Affiniti CVx offers smart features to enable you to achieve greater consistency, accessible innovation, smarter workflows and easier scalability. This is all on one familiar, industry-leading platform so you can act and decide with the ease you know and the legacy you trust.
Ultrasound Workspace is a holistic, scalable, cardiovascular viewing, analysis and reporting system which is built on the foundation of the TOMTEC-ARENA platform. It allows for top-notch clinical efficiency by providing care teams with workflow flexibility: enabling the same diagnostic capabilities on- and off-cart; analyzing multi-vendor data; leveraging AI across a wide range of applications; with a highly scalable technology platform and licensing model; and tailored comprehensive support.
Cardiovascular Workspace is a scalable and interoperable solution that combines deep clinical expertise with technological innovation to help streamline workflow and improve operational performance throughout the complete cardiovascular care continuum.
Intelligent, automated and connected Advanced Visualization solution. First-time-right, intelligent and quantitative clinical insights, designed to support your image diagnostic confidence, while still reducing your time to report through optimized workflows and results automation. IntelliSpace Portal 12 is a scalable image post-processing platform seamlessly integrated within your enterprise.
Based on its new, revolutionary fully sealed BlueSeal magnet, Ingenia Ambition X lets you experience more productive¹ helium-free MR operations. The Ingenia Ambition X delivers superb image quality even for challenging patients, and performs MRI exams up to 50% faster² with Compressed SENSE accelerations for all anatomies, in both 2D- and 3D scanning. Fast overall exam-time is achieved by simplifying patient handling at the bore with the touchless guided patient setup. Furthermore, the Ingenia Ambition offers an immersive audio-visual experience to help calm patients and guide them through MR exams.
Dynamic HeartModelA.I. and AutoStrain provide valuable insights to support cardiovascular monitoring and cardiotoxicity prevention, in close collaboration with oncologists and hematologists.”Dynamic HeartModelA.I. and AutoStrain provide valuable insights to support cardiovascular monitoring and cardiotoxicity prevention, in close collaboration with oncologists and hematologists.”
Dr Teresa López Fernández
Cardiac Imaging and Cardio-Oncology Unit Leader, La Paz University Hospital, Madrid, Spain
Documentation
External resources
1 www.escardio.org/The-ESC/Press-Office/Press-releases/Cancer-patients-are-at-higher-risk-of-dying-from-heart-disease-and-stroke
2 Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., Cutter, D. J., De Azambuja, E., De Boer, R. A., Dent, S. F., Farmakis, D., Gevaert, S. A., Gorog, D. A., Herrmann, J., Lenihan, D. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal, 43(41), 4229–4361. https://doi.org/10.1093/eurheartj/ehac244.
3 Sung, H., Ferlay, J., Siegel, RL., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021: 71: 209- 249. https://doi.org/10.3322/caac.21660.
4 Philips Cardiovascular Workspace is the commercial name of the medical device Philips IntelliSpace Cardiovascular.
5 Advanced Visualization Workspace is the commercial name for IntelliSpace Portal.
You are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueSelect country/region
Lebanon (English)